FREQUENCY OF RHEUMATIC MITRAL VALVE STENOSIS AND SEVERITY DISTRIBUTION AMONG THE AGE GROUP OF 20-45 YEARS PRESENTED TO HEALTH SETUPS OF DISTRICT SWAT: A CROSS-SECTIONAL STUDY

Authors

  • Babar Ali Khyber Medical University, Peshawar, Pakistan. Author
  • Hazrat Usman Peshawar Institute of Cardiology, Peshawar, Pakistan Author
  • Safa Gul Khyber Medical University, Peshawar, Pakistan. Author
  • Kushal Khan Khyber Medical University, Peshawar, Pakistan. Author
  • Bashir Ullah Khyber Medical University, Peshawar, Pakistan. Author
  • Saeed Ahmed Khyber Medical University, Peshawar, Pakistan. Author

DOI:

https://doi.org/10.71000/zhagtc50

Keywords:

Gender, , Rheumatic Heart Disease (RHD), , Rheumatic Fever, Mitral Stenosis (MS). , Echocardiography, Mitral Regurgitation, Valve Disease

Abstract

Background: Rheumatic heart disease (RHD) is the most prevalent acquired cardiovascular condition in developing regions, largely affecting young populations. It typically results from an autoimmune response following untreated group A streptococcal infections. The mitral valve is most frequently compromised, with disease progression often exacerbated by limited access to antibiotics, poor sanitation, and delayed healthcare-seeking behavior in underserved communities.

Objective: To determine the frequency and severity distribution of mitral valve stenosis among patients aged 20 to 45 years diagnosed with rheumatic heart disease in District Swat, Pakistan.

Methods: A descriptive cross-sectional study was carried out over four months (November to February 2024–2025) across multiple echocardiographic centers in District Swat, Khyber Pakhtunkhwa. A total of 152 patients aged 20–45 years with echocardiographically confirmed rheumatic mitral stenosis were selected using non-probability convenience sampling. Data were collected through structured questionnaires and diagnostic imaging. Severity of mitral stenosis was classified as mild (>1.6 cm²), moderate (1.0–1.6 cm²), or severe (<1.0 cm²). Data analysis was performed using SPSS version 23.

Results: Among 152 participants, 64 (42.1%) were male and 88 (57.9%) female; 104 (68.4%) were married. Most patients (94, 61.8%) were aged 20–30 years. Mitral valve involvement was isolated in 110 cases (72.4%), while tricuspid, aortic, and pulmonic valve involvement was observed in 25 (16.4%), 12 (7.9%), and 5 (3.3%) patients respectively. Moderate mitral stenosis was the most common grade (64, 42.1%), followed by mild (56, 36.8%) and severe (32, 21.1%). Mild mitral regurgitation was found in 86 patients (56.6%). Complications were present in 35 patients (23%), including arrhythmia (13, 8.6%), heart failure (12, 7.9%), respiratory complications (9, 5.9%), and stroke (1, 0.7%).

Conclusion: Rheumatic mitral stenosis is predominantly observed in young adult females, with moderate stenosis being the most frequent form. These findings highlight the need for early diagnosis and preventive strategies targeting streptococcal infections at the community level.

Author Biographies

  • Babar Ali, Khyber Medical University, Peshawar, Pakistan.

    Lecturer Cardiology, Department of Cardiology /Cardiac Perfusion, Khyber Medical University, Peshawar, Pakistan.

  • Hazrat Usman, Peshawar Institute of Cardiology, Peshawar, Pakistan

     Department of Diagnostic Cardiology, Peshawar Institute of Cardiology, Peshawar, Pakistan

  • Safa Gul, Khyber Medical University, Peshawar, Pakistan.

     Department of Cardiology /Cardiac Perfusion, Khyber Medical University, Peshawar, Pakistan.

  • Kushal Khan, Khyber Medical University, Peshawar, Pakistan.

     Department of Cardiology /Cardiac Perfusion, Khyber Medical University, Peshawar, Pakistan.

  • Bashir Ullah, Khyber Medical University, Peshawar, Pakistan.

     Department of Cardiology /Cardiac Perfusion, Khyber Medical University, Peshawar, Pakistan.

  • Saeed Ahmed, Khyber Medical University, Peshawar, Pakistan.

     Department of Cardiology /Cardiac Perfusion, Khyber Medical University, Peshawar, Pakistan.

References

Brodmann M, Cahill TJ, Hil DP, Carapetis J, Catapano AL, Chugh SS, et al. Global Burden of Cardiovascular Diseases. 2020;

Leith J, An KR, Harik L, Zhu W, Dell’Aquila M, Brashear T, et al. Cardiac Surgery to Manage Rheumatic Heart Disease in Africa Is Complex - a Geographic Perspective. Glob Heart. 2025;20(1):10.

Mebrahtom G, Hailay A, Aberhe W, Zereabruk K. Review Article Rheumatic Heart Disease in East Africa: A Systematic Review and Meta-Analysis. 2023;2023.

Sarah R. de Loizaga, MD and Andrea Z. Beaton M. Rheumatic Fever and Rheumatic Heart Disease in the United States. 2021; 50:3.

Chen Y, Jiang W. Recent Advances on the Prevention and Management of Rheumatic Heart Disease. 2025;20(1).

Kumar RK. Rheumatic fever and rheumatic heart disease. 2024.

DeCourcy1 V, Katzenellenbogen3 | Daniel Hunt2 | Ingrid Stacey3 | Emma Haynes3 | Beverley Paterson4 | Clare Huppatz5 | Marisa Gilles1 | Judith. Australian J Rural Health - 2025 - DeCourcy - Connections Reduce Rheumatic Heart Disease‐Related Mortality in Western.pdf. 2025.

Berhanu H, Tegene E, Sudhakar M, Dukessa T. International Journal of Cardiology Cardiovascular Risk and Prevention Rheumatic heart disease burden and determinants in cardiac patients: A follow up care concern in Ethiopia. 2025;24(November 2024).

Blennerhasse E, O BB, Connor OM, Gondwe H, Msimuko L, Ledwidge M, et al. The burden of rheuma . c heart disease and issues affec . ng the provision of care in Malawi: A scoping review. Abstract: 2025;1–64.

Rouhiainen O, Gatti J, Ramadani S, Stewart J, Matthews M, Fairhurst H. Missed Opportunities for Preventing or Diagnosing Acute Rheumatic Fever: A Retrospective Cohort Study of 20 Young Australians Diagnosed with Rheumatic Heart Disease on Screening Echocardiography. 2025;1–6.

Okello E, Ndagire E, Muhamed B, Sarnacki R, Murali M, Pulle J, et al. Articles Incidence of acute rheumatic fever in northern and western Uganda: a prospective, population-based study. Lancet Glob Heal [Internet]. 2021;9(10): e1423–30.

Acute rheumatic fever and rheumatic heart disease in Australia. 2023.

Study RAPF up, Kumar R, Shah JA, Solangi BA, Ammar A, Kumar M. The Burden of Short-term Major Adverse Cardiac Events and it’s The Burden of Short-term Major Adverse Cardiac Events and its Determinants after Emergency Percutaneous Coronary Revascularization: A Prospective Follow-up Study. 2022;34(2).

Lupieri A, Jha PK, Nizet V, Dutra WO, Nunes MCP, Levine RA, et al. Rheumatic heart valve disease: navigating the challenges of an overlooked autoimmune disorder. 2025;(March):1–10.

Abu-Freha N, Alamour O, Weissmann S, Esbit S, Cohen B, Gordon M, et al. Ethnic Disparities in Chronic Diseases: Comparison Between Arabs and Jews in Israel. Isr Med Assoc J. 2024 Dec;26(11):694–700.

Topçu S, Uçar T. Echocardiographic Screening of Rheumatic Heart Disease: Current Concepts and Challenges. Turkish Arch Pediatr. 2024 Jan;59(1):3–12.

1 EA a, 1, Shahzaib Ahmed aB, Sophia AhmedB, Hamza AshrafB, Umar AkramC, Shoaib AhmadD, Irfan UllahE, Mohammed KhanjiE, Wael AwadF, Vuyisile NkomoI, Fabrizio Ricci g hJ, Matthew BatesK, Mohammad Alkhalil2, Raheel Ahmed lA2 nwar AC f m n o. Comparison of mortality trends in patients with rheumatic mitral valve disease and nonrheumatic mitral valve disease: A retrospective study in US from 1999 to 2020. 2025.

Profile THE, Rhd OF. The profile of rheumatic heart disease at a tertiary hospital in KwaZulu-Natal, South Africa. 2024;(10):208–17.

Hawkins RB, Strobel RJ, Quader MA, Mehaffey JH, Joseph M, Ailawadi G. Contemporary prevalence and outcomes of rheumatic mitral valve surgery. 2022;(February):1868–74.

Ismail JAZAHARFAFAAYM. Severity of Rheumatic Mitral Stenosis: A Comparative Study of Mitral Leaflet Separation Index versus Mitral Valve Area. 2025;

Rachmawan YP, Hikmayani AA, Pratiwi W, Medika H, Hospital C, Swadaya U, et al. Gender Differences in Rheumatic Heart Disease: Data from a District Hospital in Cirebon, Indonesia. 2025;6(1):1–9.

Omran SA al K. Risk Assessment of Rheumatic Fever and Mitral Valve Stenosis in Samawah , Iraq. 2024;2024.

Shafi MJ, Nasrin S. Incidence & Pattern of Valvular Heart Disease in Patients attended in Echo Lab at a tertiary care Hospital: A single Centre Study. 2021;0.

Khan, Sher Alam, Ayesha Usman, Zahoor Islam, Rida Fatima, Irum Sajid, Sadiq Sadiq, Ayesha Saleem, and Ishfaq Aziz. 2024. “A Comprehensive Review of Immunomodulatory Drugs in Preventing Secondary Infections in Immunocompromised Patients: A Narrative Review.” Insights-Journal of Health and Rehabilitation 2 (2)

Downloads

Published

2025-05-12